These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 17111505

  • 1. Patient safety or profit: what incentives are blood shield laws and FDA regulations creating for the tissue banking industry?
    Williams JL.
    Indiana Health Law Rev; 2005; 2(1):295-328. PubMed ID: 17111505
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FDA's proposed regulatory approach to regulation of hematopoietic stem/progenitor cell products.
    Harvath L.
    Cytotherapy; 1999; 1(4):358-9. PubMed ID: 20440912
    [No Abstract] [Full Text] [Related]

  • 4. AIDS and the blood supply: an analysis of law, regulation, and public policy.
    Salbu SR.
    Wash Univ Law Q; 1996; 74(4):913-80. PubMed ID: 16273697
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The commodification of human body parts: regulating the tissue bank industry.
    Zodrow JJ.
    Southwest Univ Law Rev; 2003; 32(3):407-49. PubMed ID: 15212024
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Umbilical cord blood stem cells: my body makes them, but do I get to keep them? Analysis of the FDA proposed regulations and the impact on individual constitutional property rights.
    Fredrickson JK.
    J Contemp Health Law Policy; 1998; 14(2):477-502. PubMed ID: 9693489
    [No Abstract] [Full Text] [Related]

  • 9. Impending FDA regulations of healthcare software. First stop: blood banking. Interview by Bill W. Childs.
    Marrazzo J.
    US Healthc; 1988 Nov; 5(11):17-8. PubMed ID: 10291018
    [No Abstract] [Full Text] [Related]

  • 10. FDA issues new rule on tissue safety.
    OR Manager; 2005 Jan; 21(1):5. PubMed ID: 15707142
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tissue banking: industry grows but federal regulation lagging.
    Patterson P.
    OR Manager; 2002 Jan; 18(1):1, 9-12. PubMed ID: 11842762
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Symposium: Current concepts and controversies in tissue banking.
    Tomford WW, Malinin T, Moore TM, Rodrigo JJ, Strobos J, Woodcock J.
    Contemp Orthop; 1995 Apr; 30(4):349-61. PubMed ID: 10150357
    [No Abstract] [Full Text] [Related]

  • 16. Revisions to the requirements applicable to blood, blood components, and source plasma. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2001 Aug 06; 66(151):40886-90. PubMed ID: 11732557
    [Abstract] [Full Text] [Related]

  • 17. Tissue oversight in hospitals: the role of the transfusion services.
    Hillyer CD, Josephson CD.
    Transfusion; 2007 Feb 06; 47(2):185-7. PubMed ID: 17302760
    [No Abstract] [Full Text] [Related]

  • 18. Human tissues and reproductive cloning: new technologies challenge FDA.
    Merrill RA.
    Houst J Health Law Policy; 2002 Feb 06; 3(1):1-82. PubMed ID: 15712415
    [No Abstract] [Full Text] [Related]

  • 19. Body parts: FDA regulation of human tissue banks.
    Barons J.
    Food Drug Cosmet Med Device Law Dig; 1996 Feb 06; 13(1):26-35. PubMed ID: 11658087
    [No Abstract] [Full Text] [Related]

  • 20. Blood investigation.
    AIDS Policy Law; 1996 May 17; 11(9):12. PubMed ID: 11363471
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.